SHMT2 and colorectal carcinoma: The natural compound apigenin downregulates SHMT2 by targeting the LINC01234/SIRT3/SHMT2 axis to suppress metabolic reprogramming in CRC cells, disrupt cell cycle progression, and induce apoptosis through the downregulation of SHMT2 (Abdelmaksoud et al., 2024).